Nicotine and 17β-estradiol produce an antidepressant-like effect in female ovariectomized rats

Brain Research Bulletin

Volumn 84, Issue 3, 2011, Pages 224-228

  Kandi, P ^a   Hayslett, R L ^a  

^a MERCER UNIVERSITY   (United States)

Author keywords

17 Estradiol; Depression; Forced swim test; Nicotine

Indexed keywords

ESTRADIOL; NICOTINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; FORCED SWIMMING TEST; IMMOBILIZATION; LOCOMOTION; MONOTHERAPY; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; DRUG COMBINATIONS; DRUG SYNERGISM; ESTRADIOL; FEMALE; NICOTINE; NICOTINIC AGONISTS; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 79951682676     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2010.12.012     Document Type: Article

References (66)

1. Andreasen J.T., Olsen G.M., Wiborg O., Redrobe J.P. Antidepressant-like effects of nicotinic acetylcholine receptor antagonists, but not agonists, in the mouse forced swim and mouse tail suspension tests. J. Psychopharmacol. 2009, 23(7):797-804.
2. Andreasen J.T., Redrobe J.P. Antidepressant-like effects of nicotine and mecamylamine in the mouse forced swim and tail suspension tests: role of strain, test and sex. Behav. Pharmacol. 2009, 20(3):286-295.
3. Avis N., Brambilla D., McKinlay S., Vass K. A longitudinal analysis of the association between menopause and depression: results from the Massachusetts women's health study. Ann. Epidemiol. 1994, 4:214-220.
4. Bloch M., Schmidt P., Danaceau M., Murphy J., Nieman L., Rubinow D. Effects of gonadal steroids in women with a history of postpartum depression. Am. J. Psychiatr. 2000, 157:924-930.
5. Brown C., Madden P., Palenchar D., Cooper-Patrick L. The association between depressive symptoms and cigarette smoking in an urban primary care sample. Int. J. Psychiatr. Med. 2000, 30:15-26.
6. Caldarone B.J., Harrist A., Cleary M.A., Beech R.D., King S.L., Picciotto M.R. High-affinity nicotinic acetylcholine receptors are required for antidepressant effects of amitriptyline on behavior and hippocampal cell proliferation. Biol. Psychiatry 2004, 56(9):657-664.
7. Campbell S. MacQueen Glenda, the role of the hippocampus in the pathophysiology of major depression. J. Psychiatry Neurosci. 2004, 29:417-425.
8. Clarke P.B., Kumar R. Characterization of the locomotor stimulant action of nicotine in tolerant rats. Br. J. Pharmacol. 1983, 80(3):587-594.
9. Djuric V.J., Dunn E., Overstreet D.H., Dragomir A., Steiner M. Antidepressant effects of ingested nicotine in female rats of Flinders Resistant and Sensitive Lines. Physiol. Behav. 1999, 67:533-537.
10. Dunbar G.C., Kuchibhatla R., Kumar R. Mecamylamine in the treatment of depressed patients who were inadequate responders to citalopram first-line therapy; a double-blind placebo controlled add-on study. J. Psychopharmacol. 2007, 21(7):A40.
11. Detke M., Rickels M., Lucki I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology 1995, 121:66-72.
12. Estrada-Camarena E., Fernandez-Guasti A., Lopez-Rubalcava C. Antidepressant-like effect of different estrogenic compounds in the forced swimming test. Neuropsychopharmacology 2003, 28:830-838.
13. Frank E., Kupfer D., Jacob M., Blumenthal S., Jarrett D. Pregnancy-related affective episodes among women with recurrent depression. Am. J. Psychiatr. 1987, 144:288-293.
14. Frye C., Wawrzycki J. Effect of prenatal stress and gonadal hormone condition on depressive behaviors of female and male rats. Horm. Behav. 2003, 44:319-326.
15. George T.P., Sacco K.A., Vessicchio J.C., et al. Nicotinic antagonist augmentation of selective serotonin reuptake inhibitor-refractory major depressive disorder: a preliminary study. J. Clin. Psychopharmacol. 2008, 28(3):340-344.
16. Grant B.F., Hasin D.S., Chou S.P., Stinson F.S., Dawson D.A. Nicotine dependence and psychiatric disorders in the United States. Arch. Gen. Psychiatr. 2004, 61:1107-1115.
17. Joffe H., Petrillo L.F., Viguera A.C., Gottshcall H., Soares C.N., Hall J.E., Cohen L.S. Treatment of premenstrual worsening of depression with adjunctive oral contraceptive pills: a preliminary report. J. Clin. Psychiatry 2007, 68(12):1954-1962.
18. P. Kandi, R. Hayslett, Cytisine, a modulator of nicotinic receptors, produces antidepressant-like effects in female rats, AAPS Abstracts November 2010.
19. Ke L., Lukas R.J. Effects of steroid exposure on ligand binding and functional activities of diverse nicotinic acetylcholine receptor subtypes. J. Neurochem. 1996, 67:1100-1112.
20. Kessler R., McGonagle K., Swartz M., Blazer D., Nelson C. Sex and depression in the National Comorbidity Survey. I. Lifetime prevalence, chronicity, and recurrence. J. Affect. Disord. 1993, 29:85-96.
21. Kessler R., McGonagle K., Zhao S., Nelson C., Hughes M., Eshleman S., Wittchen H., Kendler K. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Arch. Gen. Psychiatr. 1994, 36:8-19.
22. Kessler R., Berglund P., Demler O., Jin R., Koretz D., Merikangas K., Rush A., Walters E., Wang P. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). J. Am. Med. Assoc. 2003, 23:3095-3105.
23. Kessler R., Chiu W., Demler O., Walters E. Prevalence, severity, and comorbidity of twelve-month DSM-IV disorders in the National Comorbidity Survey Replication (NCS-R). Arch. Gen. Psychiatr. 2005, 6:617-627.
24. Kita T., Nakashima T., Kurogochi Y. Circadian variation of nicotine-induced ambulatory activity in rats. Jpn. J. Pharmacol. 1986, 41(1):55-60.
25. Kumar R., Robson K. A prospective study of emotional disorders in childbearing women. Br. J. Psychiatr. 1984, 144:35-47.
26. Lapchak P.A., Araujo D.M., Quirion R., Beaudet A. Chronic estradiol treatment alters central cholinergic function in the female rat: effect on choline acetyltransferase activity, acetylcholine content, and nicotinic autoreceptor function. Brain Res. 1990, 525:249-255.
27. Lippiello P.M., Beaver J.S., Gatto G.J., James J.W., Jordan K.G., Traina V.M., Xie J., Bencherif M. TC-5214 (S-(+)-mecamylamine): a neuronal nicotinic receptor modulator with antidepressant activity. CNS Neurosci. Ther. 2008, 14(4):266-277.
28. McClernon F.J., Hiott F.B., Westman E.C., Rose J.E., Levin E.D. Transdermal nicotine attenuates depression symptoms in nonsmokers: a double-blind, placebo-controlled trial. Psychopharmacology 2006, 189:125-133.
29. Mineur Y.S., Eibl C., Young G., Kochevar C., Papke R.L., Gundisch D., Picciotto M.R. Cytisine-based nicotinic partial agonists as novel antidepressant compounds. J. Pharmacol. Exp. Ther. 2009, 329(1):377-386.
30. Mineur Y.S., Somenzi O., Picciotto M.R. Cytisine, a partial agonist of high affinity nicotinic acetylcholine receptors, has antidepressant-like properties in male C57BL/6J mice. Neuropharmacology 2007, 52(5):1256-1262.
31. Morrison C.F., Stephenson J.A. The occurrence of tolerance to a central depressant effect of nicotine. Br. J. Pharmacol. 1972, 46:151-156.
32. Oinonen K., Mazmanian D. To what extent do oral contraceptives influence mood and affect?. J. Affect. Disord. 2002, 70(3):229-240.
33. Okada M., Hayashi N., Komentani M., Nakao K., Inukai T. Influences of ovariectomy and continuous replacement of 17beta-estradiol on the tail skin temperature and behavior in the forced swimming test in rats. Jpn. J. Pharmacol. 1997, 73:93-96.
34. Paradiso K., Zhang J., Steinbach J.H. The C terminus of the human nicotinic alpha 4beta 2 receptor forms a binding site required for potentiation by an estrogenic steroid. J. Neurosci. 2001, 21:6561-6568.
35. Paradiso K., Sabey K., Evers A.S., Zorumski C.F., Covey D.F., Steinbach J.H. Steroid inhibition of rat neuronal nicotinic alpha4beta2 receptors expressed in HEK 293 cells. Mol. Pharmacol. 2000, 58(2):341-351.
36. Payne J. The role of estrogen in mood disorders in women. Int. Rev. Psychiatry 2003, 15:280-290.
37. Popik P., Kozela E., Krawczyk M. Nicotine and nicotinic receptor antagonists potentiate the antidepressant-like effects of imipramine and citalopram. Br. J. Pharmacol. 2003, 139(6):1196-1202.
38. Porsolt R., Le Pichon M., Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature 1977, 266:730-732.
39. Prange A. Estrogen may well affect response to antidepressant. J. Am. Med. Assoc. 1972, 219:143-144.
40. Prossnitz E.R., Arterburn J.B., Sklar L.A. GPR30: a G protein-coupled receptor for estrogen. Mol. Cell. Endocrinol. 2007, 265(1):138-142.
41. Quattrocki E., Baird A., Yurgelun-Todd D. Biological aspects of the link between smoking and depression. Harv. Rev. Psychiatry 2000, 8:99-110.
42. Rabenstein R.L., Caldarone B.J., Picciotto M.R. The nicotinic antagonist mecamylamine has antidepressant-like effects in wild-type but not beta2- or alpha7-nicotinic acetylcholine receptor subunit knockout mice. Psychopharmacology 2006, 189(3):395-401.
43. Salin-Pascual R.J. Relationship between mood improvement and sleep changes with acute nicotine administration in nonsmoking major depressed patients. Rev. Invest. Clin. 2002, 69:36-40.
44. Schmidt P., Neiman L., Danaceau M., Adams L., Rubinow D. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N. Eng. J. Med. 1998, 338:209-216.
45. Schmidt P., Neiman L., Danaceau M., Tobin M., Roca C., Murphy J., Rubinow D. Estrogen replacement in perimenopause-related depression: a preliminary report. Am. J. Obstet. Gynecol. 2000, 183:414-420.
46. Schneider L., Small G., Clary C.M. Estrogen replacement therapy and antidepressant response to sertraline in older depressed women. Am. J. Geriatr. Psychiatr. 2001, 9:393-399.
47. Schneider L., Small G., Hamilton S., Bystrisky A., Nemeroff C., Meyers B. Estrogen replacement and response to fluoxetine in surgically menopausal women. Am. J. Geriatr. Psychiatr. 1997, 5:97-106.
48. Semba J., Mataki C., Yamada S., Nanakai M., Toru M. Antidepressant-like effects of chronic nicotine on learned helplessness paradigm in rats. Biol. Psychiatry 1998, 43(March (5)):389-391.
49. Shima N., Yamaguchi Y., Yuri K. Distribution of estrogen receptor beta mRNA-containing cells in ovariectomized and estrogen-treated female rat brain. Anat. Sci. Int. 2003, 78:85-97.
50. Shingo A., Yonezawa M., Sakurai K., Kito S. Nicotine inhibits estrogen response element binding in the rat brain. J. Neural Transm. 2000, 107:1491-1495.
51. Soares C., Almeida O., Joffe H., Cohen L. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women. Arch. Gen. Psychiatr. 2001, 58:529-534.
52. Spring B., Cook J.W., Appelhans B., Maloney A., Richmond M., Vaughn J., Hedeker D. Nicotine effects on affective response in depression-prone smokers. Psychopharmacology (Berl.) 2008, 196:461-471.
53. Stolerman I.P., Fink R., Jarvik M.E. Acute and chronic tolerance to nicotine by activity in rats. Psychopharmacology 1973, 30:329-342.
54. Strong D.R., Cameron A., Feuer S., Cohn A., Abrantes A.M., Brown R.A. Single versus recurrent depression history: differentiating risk factor among current US smokers. Drug Alcohol Depend. 2010, 109:90-95.
55. Tizabi Y., Rezvani A.H., Russell L.T., Tyler K.Y., Overstreet D.H. Depressive characteristics of FSL rats: involvement of central nicotinic receptors. Pharmacol. Biochem. Behav. 2000, 66(1):73-77.
56. Tizabi Y., Getachew B., Rezvani A.H., Hauser S.R., Overstreet D.H. Antidepressant-like effects of nicotine and reduced nicotinic receptor binding in the Fawn-Hooded rat, an animal model of co-morbid depression and alcoholism. Prog. Neuropsychopharmacol. Biol. Psychiatry 2009, 33(3):398-402.
57. Tizabi Y., Overstreet D., Rezvani A., Louis V., Clark E., Janowsky D., Kling M. Antidepressant effects of nicotine in an animal model of depression. Psychopharmacology 1999, 142(2):193-199.
58. Tizabi Y., Hauser S.R., Tyler K.Y., Getachew B., Madani R., Sharma Y., Manaye K.F. Effects of nicotine on depressive-like behavior and hippocampal volume of female WKY rats. Prog. Neuropsychopharmacol. Biol. Psychiatry 2010, 34(1):62-69.
59. Trosclair A., Dube S. Smoking among adults reporting lifetime depression, anxiety, anxiety with depression, and major depressive episode, United States, 2005-2006. Addict. Behav. 2010, 35:438-443.
60. Vazquez-Palacios G., Bonilla-Jaime H., Velazquez-Moctezuma J. Antidepressant effects of nicotine and fluoxetine in an animal model of depression induced by neonatal treatment with clomipramine. Prog. Neuropsychopharmacol. Biol. Psychiatry 2005, 29(1):39-46.
61. Vazquez-Palacios G., Bonilla Jaime H., Velazquez-Moctezuma J. Antidepressant-like effects of the acute and chronic administration of nicotine in the rat forced swimming test and its interaction with fluoxetine. Pharmacol. Biochem. Behav. 2004, 78:165-169.
62. Walf A., Frye C. Antianxiety and antidepressive behavior produced by physiological estradiol regimen may be modulated by hypothalamic-pituitary-adrenal axis activity. Neuropsychopharmacology 2005, 30:1288-1301.
63. Walf A., Frye C. ERbeta-selective estrogen receptor modulators produce antianxiety behavior when administered systemically to ovariectomized rats. Neuropsychopharmacology 2005, 30(9):1598-1609.
64. Walf A., Frye C. Administration of estrogen receptor beta-specific selective estrogen receptor modulators to the hippocampus decrease anxiety and depressive behavior of ovariectomized rats. Pharmacol. Biochem. Behav. 2007, 86(2):407-414.
65. Walf A., Ciriza I., Garcia-Segura L.M., Frye C. Antisense oligodeoxynucleotides for estrogen receptor-β and α attenuate estradiol's modulation of affective and sexual behavior, respectively. Neuropsychopharmacology 2007, 1-10.
66. Walf A., Rhodes M., Frye C. Antidepressant effects of ERbeta-selective estrogen receptor modulators in the forced swim test. Pharmacol. Biochem. Behav. 2004, 78(3):523-529.